Literature DB >> 10415122

Direct interaction of STAT4 with the IL-12 receptor.

B B Yao1, P Niu, C S Surowy, C R Faltynek.   

Abstract

Signal transduction by interleukin-12 (IL-12) requires phosphorylation and activation of STAT4. Direct interaction of the SH2 domain of STAT4 with a phosphotyrosine residue in the IL-12 receptor has been proposed to be required for the subsequent STAT4 phosphorylation. The IL-12 receptor beta2 subunit contains three tyrosine residues in its cytoplasmic domain. To test the hypothesis that one of these tyrosines is involved in binding STAT4, phosphopeptides were synthesized according to the amino acid sequences surrounding each of these tyrosine residues. Only the phosphopeptide containing pTyr800 strongly bound to STAT4 in a cell-free binding assay. When this phosphopeptide was introduced into TALL-104 cells, it blocked IL-12-induced STAT4 phosphorylation by competing with the IL-12 receptor for binding to STAT4. A series of alanine replacements was performed in this phosphopeptide to elucidate which amino acids surrounding the pTyr800 residue are critical for STAT4 binding. To summarize, the site on the IL-12 receptor which binds STAT4 can be described as -T-X-X-G-pY(800)-L-, where the core G-pY(800)-L motif is critical for the binding; the threonine at the pY-4 position has only a minor contribution and X represents amino acids not critical for the binding. These results demonstrate that only a small region of the IL-12 receptor is critically involved in binding STAT4 and suggest the feasibility that small molecule inhibitors could be identified which interfere with IL-12 signal transduction for treatment of autoimmune diseases. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415122     DOI: 10.1006/abbi.1999.1302

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  A novel class of anti-IL-12p40 antibodies: potent neutralization via inhibition of IL-12-IL-12Rβ2 and IL-23-IL-23R.

Authors:  Adam W Clarke; Lynn Poulton; Hoi Yi Wai; Stuart A Walker; Shanti David Victor; Teresa Domagala; Dragana Mraovic; Danyal Butt; Nina Shewmaker; Philip Jennings; Anthony G Doyle
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

Review 3.  Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function.

Authors:  Esther van de Vosse; Elgin G R Lichtenauer-Kaligis; Jaap T van Dissel; Tom H M Ottenhoff
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

Review 4.  Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.

Authors:  D A Lammas; J L Casanova; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 5.  The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.

Authors:  Christoph Hölscher
Journal:  Med Microbiol Immunol       Date:  2003-06-27       Impact factor: 3.402

6.  Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.

Authors:  Doreen M Floss; Simone Mrotzek; Tobias Klöcker; Jutta Schröder; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

7.  STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk.

Authors:  A-K Abelson; A M Delgado-Vega; S V Kozyrev; E Sánchez; R Velázquez-Cruz; N Eriksson; J Wojcik; M V P Linga Reddy; G Lima; S D'Alfonso; S Migliaresi; V Baca; L Orozco; T Witte; N Ortego-Centeno; H Abderrahim; B A Pons-Estel; C Gutiérrez; A Suárez; M F González-Escribano; J Martin; M E Alarcón-Riquelme
Journal:  Ann Rheum Dis       Date:  2008-11-19       Impact factor: 19.103

8.  Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.

Authors:  Caleb R Glassman; Yamuna Kalyani Mathiharan; Kevin M Jude; Leon Su; Ouliana Panova; Patrick J Lupardus; Jamie B Spangler; Lauren K Ely; Christoph Thomas; Georgios Skiniotis; K Christopher Garcia
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

9.  Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.

Authors:  Alexandra Zhernakova; Eli A Stahl; Gosia Trynka; Soumya Raychaudhuri; Eleanora A Festen; Lude Franke; Harm-Jan Westra; Rudolf S N Fehrmann; Fina A S Kurreeman; Brian Thomson; Namrata Gupta; Jihane Romanos; Ross McManus; Anthony W Ryan; Graham Turner; Elisabeth Brouwer; Marcel D Posthumus; Elaine F Remmers; Francesca Tucci; Rene Toes; Elvira Grandone; Maria Cristina Mazzilli; Anna Rybak; Bozena Cukrowska; Marieke J H Coenen; Timothy R D J Radstake; Piet L C M van Riel; Yonghong Li; Paul I W de Bakker; Peter K Gregersen; Jane Worthington; Katherine A Siminovitch; Lars Klareskog; Tom W J Huizinga; Cisca Wijmenga; Robert M Plenge
Journal:  PLoS Genet       Date:  2011-02-24       Impact factor: 5.917

10.  Role of MEK1 in TLR4 Mediated Signaling.

Authors:  Christian Bauerfeld; Lobelia Samavati
Journal:  J Cell Signal       Date:  2017-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.